Eiko Lifesciences Ltd vs Grauer Weil India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 22, 2026

Key Highlights

The Latest Trading Price of Eiko Lifesciences Ltd is ₹ 52.4 as of 20 Mar 15:30 . The P/E Ratio of Eiko Lifesciences Ltd changed from 31.1 on March 2025 to 31.1 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Grauer & Weil (India) Ltd changed from 12.9 on March 2021 to 23.6 on March 2025 . This represents a CAGR of 12.84% over 5 years The Market Cap of Eiko Lifesciences Ltd changed from ₹ 65.15 crore on March 2025 to ₹ 65.15 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Grauer & Weil (India) Ltd changed from ₹ 888.69 crore on March 2021 to ₹ 3719 crore on March 2025 . This represents a CAGR of 33.15% over 5 years The revenue of Eiko Lifesciences Ltd for the Dec '25 is ₹ 12.33 crore as compare to the Sep '25 revenue of ₹ 11.97 crore. This represent the growth of 3.01% The revenue of Grauer & Weil (India) Ltd for the Dec '25 is ₹ 302.54 crore as compare to the Sep '25 revenue of ₹ 302.51 crore. This represent the growth of 0.01% The ebitda of Eiko Lifesciences Ltd for the Dec '25 is ₹ 2.22 crore as compare to the Sep '25 ebitda of ₹ 2.07 crore. This represent the growth of 7.25% The ebitda of Grauer & Weil (India) Ltd for the Dec '25 is ₹ 50.59 crore as compare to the Sep '25 ebitda of ₹ 54.66 crore. This represent the decline of -7.45% The net profit of Eiko Lifesciences Ltd changed from ₹ 0.35 crore to ₹ 1.43 crore over 7 quarters. This represents a CAGR of 123.51% The net profit of Grauer & Weil (India) Ltd changed from ₹ 50.71 crore to ₹ 32.33 crore over 7 quarters. This represents a CAGR of -22.68% The Dividend Payout of Eiko Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Grauer & Weil (India) Ltd changed from 16.28 % on March 2021 to 14.44 % on March 2025 . This represents a CAGR of -2.37% over 5 years .

About Eiko Lifesciences Ltd

Eiko Lifesciences Limited was originally incorporated on January 07, 1977, under the name Narendra Investments (Delhi) Limited.
Later, the Company changed its name from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited effective from June 24, 2021.
Earlier, the Company engaged in sale and purchase of shares and securities.
At present, the Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally. The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India.

About Grauer & Weil (India) Ltd

Incorporated in 1957 as a private limited company, Grauer & Weil (India) Private Limited (GWL) was converted into a public limited company in February, 1961.
The Company is a pioneer in the world to offer complete corrosion protection solutions for all types of substrates across various industry segments.
It is presently engaged in the business of manufacturing and selling of Surface Finishings besides Engineering and Mall business.
The Company presently has its manufacturing facilities in Dadra, Vapi (Gujarat), Barotiwala (Himachal Pradesh), Samba (Jammu & Kashmir) besides Engineering division at Khed (Pune District) and Mall at Kandivli (Mumbai). After the start up of Chemical production in 1957, the Company ventured into manufacturing of engineering equipment in 1964 to provide complete electroplating solutions to its customers.

FAQs for the comparison of Eiko Lifesciences Ltd and Grauer & Weil (India) Ltd

Which company has a larger market capitalization, Eiko Lifesciences Ltd or Grauer & Weil (India) Ltd?

Market cap of Eiko Lifesciences Ltd is 75 Cr while Market cap of Grauer & Weil (India) Ltd is 2,593 Cr

What are the key factors driving the stock performance of Eiko Lifesciences Ltd and Grauer & Weil (India) Ltd?

The stock performance of Eiko Lifesciences Ltd and Grauer & Weil (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Eiko Lifesciences Ltd and Grauer & Weil (India) Ltd?

As of March 22, 2026, the Eiko Lifesciences Ltd stock price is INR ₹52.4. On the other hand, Grauer & Weil (India) Ltd stock price is INR ₹57.19.

How do dividend payouts of Eiko Lifesciences Ltd and Grauer & Weil (India) Ltd compare?

To compare the dividend payouts of Eiko Lifesciences Ltd and Grauer & Weil (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.